Risk of Emergency Operations, Adverse Maternal and Neonatal Outcomes according to the Planned Gestational Age for Cesarean Delivery.

BACKGROUND: The objective of this study was to assess the risk of emergency cesarean deliveries (CDs) and adverse neonatal/maternal outcomes according to the planned gestational age at delivery (GAD) for elective CD.
METHODS: The study population consisted of term singleton pregnant women who were booked for elective CD and were subsequently delivered at term by CD, after excluding cases with a trial of labor. The relationship between the planned GAD, risk of emergency CD prior to planned date, and adverse neonatal/maternal outcomes were determined.
RESULTS: The frequency of emergency CD, adverse neonatal and maternal outcomes were 9.5%, 4.5%, and 5.9%, respectively. The risk of emergency CD prior to the planned delivery date increased significantly according to the planned GAD (5.8% at 37 weeks, 8.2% at 38 weeks, 13.6% at 39 weeks, and 26.7% at 40 weeks or more of planned GAD, P = 0.005). Emergency CD was associated with an increased risk of adverse maternal outcomes, whereas the risk of adverse neonatal outcomes did not differ. In the total study population including both cases with elective and emergency CD, the risk of adverse maternal outcomes did not increase according to the planned GAD, and the risk of adverse neonatal outcomes decreased significantly according to the planned GAD.
CONCLUSION: The risk of emergency CD increased as the planned GAD increased, but the risk of adverse maternal outcomes did not increase and the risk of adverse neonatal outcomes decreased significantly according to the planned GAD in the total study population including elective/emergency CD.

INTRODUCTION

Early term delivery, defined as term delivery at 37–38 weeks of gestation, has been reported to be associated with the risk of neonatal morbidity, and this relationship has also been demonstrated in cases with elective cesarean delivery (CD).12345 According to these evidences, it has been recommended to postpone elective CD until late term (39 weeks of gestation or later).6

Planning the date of elective CD in the late term period may increase the risk of emergent CD, which could be a risk factor for maternal/neonatal morbidity. Nevertheless, most studies of adverse neonatal outcomes and the timing of CDs are based on elective CDs after excluding cases with emergent CD.2789

To address this issue, we assessed the risk of emergent CD prior to the planned delivery date and adverse neonatal/maternal outcomes according to the planned gestational age at delivery (GAD) for elective CD.

METHODS

Study design

The study population consisted of consecutive term pregnant women who were booked for elective CD and were subsequently delivered at term (gestational age at or after 37 weeks) in Seoul National University Hospital between January 2003 and February 2011. In this study period when the conception of early term deliveries has not been universally implemented, the delivery timing was decided at the discretion of the attending obstetrician based on the mother's preference. Cases in which a trial of labor was undertaken prior to CD, cases in which the elective dating of CD was not completed, cases of fetal anomaly or fetal death in utero, cases with maternal disease that could affect the fetal outcome (hypertensive disease in pregnancy, gestational diabetes requiring insulin therapy, overt diabetes, history of maternal cardiac/renal/connective tissues disease, human immunodeficiency virus [HIV] infection, clinical chorioamnionitis prior to delivery, active rhesus or other blood type antagonism, and maternal infectious disease such as toxoplasmosis, syphilis, rubella, cytomegalovirus, or herpes), or cases with an obstetric condition that could affect the fetal outcome (non-reassuring fetal status, placenta previa, placenta accreta, placental abruption, nonvertex presentation with unsuccessful version) were excluded.

The relationship between the planned GAD for elective CD (planned GAD), the rate of emergent CD due to labor/ruptured membranes prior to the planned delivery date, and the risk of adverse neonatal/maternal outcomes were determined in the study population.

Adverse neonatal and maternal outcomes

Adverse neonatal outcomes were defined as the presence of neonatal mortality, adverse respiratory outcomes (respiratory distress syndrome, transient tachypnea of newborn, or need for respiratory assistant such as continuous positive airway pressure or ventilator), proven congenital sepsis, hypoglycemia, seizures, necrotizing enterocolitis, hypoxic ischemic encephalopathy, cardiopulmonary resuscitation, 5-minute Apgar Score ≤ 3, admission to the neonatal intensive care unit (NICU), or prolonged hospitalization for more than 10 days. The criteria for adverse neonatal outcomes were adapted from the criteria of Tita et al.2 and Ghartey et al.1 with modification.

Adverse maternal outcomes included a primary composite of death, uterine atony, need for transfusion, uterine artery embolization, peripartum hysterectomy, cystostomy, broad ligament hematoma, uterine artery ligation, uterine rupture, wound dehiscence, admission to the intensive care unit, endometritis, thromboembolic complications, or postoperative ileus. The criteria for adverse maternal outcomes were adapted from the criteria of Tita et al.10 with modification.

Statistical analysis

Proportions were compared with Fisher's exact test, and comparisons of continuous variables between groups were performed with a Mann-Whitney U test or Kruskal-Wallis analysis of variance as appropriate. Logistic regression analysis was conducted for multivariate analysis. P values < 0.05 were considered significant.

Ethics statement

The Institutional Review Board of the Seoul National University Hospital approved the study, and we followed the ethical standards for human experimentation established in the Declaration of Helsinki.

RESULTS

Study population

During the study period, a total of 1,915 singleton pregnant women delivered term neonates (≥ 37 weeks of gestation) by cesarean section. After excluding cases in which a trial of labor was undertaken (n = 359), cases with fetal anomaly or fetal death in utero (n = 140), cases with maternal disease that could affect the fetal outcome (n = 186), cases with an obstetric condition that could affect the fetal outcome (n = 172), cases in which the elective dating of CD was not completed (n = 12), and cases with incomplete medical records (n = 11), the remaining 1,035 cases were included in the analysis. Among these 1,035 women, 937 patients were delivered on the planned delivery date by elective operation, whereas 98 women underwent emergency CD prior to planned delivery date due to the onset of labor or ruptured membranes.

Adverse neonatal/maternal outcomes in elective CD

In the total study population of 1,035 women, 103 women were scheduled for elective CD at 37–37+6 weeks of gestation, 681 women at 38–38+6 weeks, 236 women at 39–39+6 weeks, and 15 women at 40 weeks of more. Among these women, 937 (90.5%) were delivered by elective CD on the planned delivery date. The relationship between the GAD and risk of adverse neonatal/maternal outcomes were determined in these 937 women with elective CD. As shown in Table 1, the risk of adverse neonatal outcomes decreased significantly with advancing GAD. The rate of adverse maternal outcomes did not differ according to the GAD. The association between the GAD and adverse neonatal outcomes remained significant after adjustment for indication of CD and small for gestational age (P < 0.01).

Table 1

Clinical characteristics and adverse neonatal/maternal outcomes according to the GAD among women who were delivered by elective CD

Characteristics			37–37+6 wk (n = 97)	38–38+6 wk (n = 625)	39–39+6 wk (n = 204)	≥ 40 wk (n = 11)	Pa	Pb
Maternal characteristics
	Maternal age, yr		33 ± 4	33 ± 4	34 ± 4	32 ± 3	NS	NS
	Marriedc		91/92 (98.9)	590/592 (99.7)	197/197 (100)	10/10 (100)	NS	NS
	Nulliparityc		25 (26)	173 (28)	72 (35)	5 (46)	0.098	0.086
Indication for CDc							< 0.001	< 0.001
	Previous CD		66 (68)	425 (68)	112 (55)	4 (36)
	Malpresentation		13 (13)	97 (16)	58 (28)	4 (36)
	Previous uterine surgery		9 (9)	61 (10)	12 (6)	0 (0)
	Others		9 (9)	42 (7)	22 (11)	3 (27)
Neonatal characteristics
	Malec		50 (52)	302 (48)	103 (51)	4 (36)	NS	NS
	Birthweight, g		3,168 ± 340	3,208 ± 353	3,357 ± 419	3,578 ± 452	< 0.001	< 0.001
	Small for gestational agec		1 (1)	19 (3)	11 (5)	0 (0)	NS	NS
Adverse neonatal outcomesd
	Any adverse outcome or death		10 (10.3)	25 (4.0)	6 (2.9)	0 (0)	< 0.010	< 0.050
		Mortality	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		RDS or TTN	1 (1.0)	5 (0.8)	0 (0)	0 (0)	NS	NS
		Need for respiratory assistant such as CPAP or ventilator	2 (2.1)	3 (0.5)	0 (0)	0 (0)	< 0.050	< 0.050
		Proven sepsis	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Hypoglycemia (< 35 mg/dL)	0 (0)	2 (0.3)	0 (0)	0 (0)	NS	NS
		Admission to the NICU	5 (5.2)	5 (0.8)	3 (1.5)	0 (0)	0.073	0.080
		5-min Apgar score ≤ 3	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Hospitalization > 10 day	8 (8.2)	17 (2.7)	4 (2.0)	0 (0)	< 0.050	< 0.050
Adverse maternal outcomesd
	Any adverse outcome or death		4 (4.1)	37 (5.9)	9 (4.4)	0 (0)	NS	NS
		Death	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Uterine artery embolization	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Hysterectomy	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Cystostomy	0 (0)	3 (0.5)	2 (1.0)	0 (0)	NS	NS
		Uterine artery ligation	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Transfusion	4 (4.1)	24 (3.8)	3 (1.5)	0 (0)	NS	NS
		Atony	0 (0)	9 (1.4)	4 (2.0)	0 (0)	NS	NS
		Uterine rupture	0 (0)	1 (0.2)	0 (0)	0 (0)	NS	NS
		Wound dehiscence	0 (0)	2 (0.3)	0 (0)	0 (0)	NS	NS
		Admission in the intensive care unit	0 (0)	1 (0.2)	0 (0)	0 (0)	NS	NS
		Endometritis	0 (0)	1 (0.2)	0 (0)	0 (0)	NS	NS
		Thromboembolic complication	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Postoperative ileus	0 (0)	2 (0.3)	1 (0.5)	0 (0)	NS	NS

Data are shown as mean ± standard deviation or number (%).

GAD = gestational age at delivery, CD = cesarean delivery, RDS = respiratory distress syndrome, TTN = transient tachypnea of newborn, CPAP = continuous positive airway pressure, NICU = neonatal intensive care unit, NS = not significant.

aP tested for total; bP tested from 37 to 39 weeks only; cAnalyzed by χ2 test; dAnalyzed by χ2 test for trend.

The risk of emergency operation according to the planned GAD and adverse neonatal/maternal outcomes

In the total study population of 1,035 women, 98 women (9.5%) were delivered by emergent CD prior to the planned delivery date. Fig. 1 shows the risk of emergent CD according to the planned GAD, and the risk of emergent delivery increased significantly with increasing planned GAD.

Fig. 1

The risk of emergent cesarean delivery according to the planned gestational age at delivery. P = 0.005 by χ2 test for trend.

Table 2 compares the clinical characteristics and the risk of adverse neonatal/maternal outcomes between cases of elective CD (n = 937) and cases of emergent CD (n = 98). Women undergoing emergent CD had a greater planned GAD than those undergoing elective CD (the mean planned GAD: 38.8 weeks in cases of emergent CD vs. 38.5 weeks in cases of elective CD, P < 0.001). The risk of adverse neonatal outcomes did not differ by the type of CD (elective vs. emergent). However, women who underwent emergent CD had a greater risk of adverse maternal outcomes than those who underwent elective CD and this relationship between emergent CD and adverse maternal outcomes remained significant after adjustment for the maternal age, GAD, and indication for CD (Table 3).

Table 2

Clinical characteristics and adverse neonatal/maternal outcomes between cases of elective CD and cases of emergent CD

Characteristics			Elective CD (n = 937)	Emergent CD (n = 98)	P
Mean planned GAD, wk			38.5 ± 0.6	38.8 ± 0.7	< 0.001
Planned GAD					< 0.010
	37–37+6 wk		97 (10)	6 (6)
	38–38+6 wk		625 (67)	56 (57)
	39–39+6 wk		204 (22)	32 (33)
	≥ 40 wk		11 (1)	4 (4)
GAD, wk			38.5 ± 0.6	38.2 ± 0.7	< 0.001
Maternal characteristics
	Maternal age, yr		33 ± 4	34 ± 4	NS
	Married		888/891 (99.7)	92/93 (98.9)	NS
	Nulliparity		275 (29)	30 (31)	NS
Indications for CD					NS
	Previous CD		607 (65)	57 (58)
	Malpresentation		172 (18)	26 (27)
	Previous uterine surgery		82 (9)	8 (8)
	Other		76 (8)	7 (7)
Neonatal characteristics
	Male		459 (49)	52 (53)	NS
	Birthweight, g		3,241 ± 375	3,134 ± 420	< 0.050
	Small for gestational age		31 (3)	7 (7)	0.081
Adverse neonatal outcomes
	Any adverse outcome or death		41 (4.4)	6 (6.1)	NS
		Mortality	0 (0)	0 (0)	-
		RDS or TTN	6 (0.6)	1 (1.0)	NS
		Need for respiratory assistant such as CPAP or ventilator	5 (0.5)	0 (0)	NS
		Proven sepsis	0 (0)	0 (0)	-
		Hypoglycemia (< 35 mg/dL)	2 (0.2)	1 (1.0)	NS
		Admission to the NICU	13 (1.4)	3 (3.1)	NS
		5-min Apgar score ≤ 3	0 (0)	0 (0)	-
		Hospitalization > 10 day	29 (3.1)	2 (2.0)	NS
Adverse maternal outcomes
	Any adverse outcome or death		50 (5.3)	11 (11.2)	< 0.050
		Death	0 (0)	0 (0)	-
		Uterine artery embolization	0 (0)	0 (0)	-
		Hysterectomy	0 (0)	1 (1.0)	0.095
		Cystostomy	5 (0.5)	1 (1.0)	NS
		Uterine artery ligation	0 (0)	0 (0)	-
		Transfusion	31 (3.3)	5 (5.1)	NS
		Atony	13 (1.4)	4 (4.1)	0.069
		Uterine rupture	1 (0.1)	1 (1.0)	0.180
		Wound dehiscence	2 (0.2)	2 (2.0)	< 0.050
		Admission to intensive care unit	1 (0.1)	1 (1.0)	0.180
		Endometritis	1 (0.1)	0 (0)	NS
		Thromboembolic complication	0 (0)	0 (0)	-
		Postoperative ileus	3 (0.3)	2 (2.0)	0.073

Data are shown as mean ± standard deviation or number (%).

GAD = gestational age at delivery, CD = cesarean delivery, RDS = respiratory distress syndrome, TTN = transient tachypnea of newborn, CPAP = continuous positive airway pressure, NICU = neonatal intensive care unit, NS = not significant.

Table 3

Relationship of various independent variables with the risk of adverse maternal outcomes analyzed by overall logistic regression analysis

Variables	OR	95% CI	P
GAD	0.895	0.574–1.396	NS
Emergent CD	2.117	1.041–4.303	< 0.050
Maternal age, yr	1.074	1.007–1.145	< 0.050
Indication of CD: previous CD	0.691	0.405–1.179	NS

GAD = gestational age at delivery, CD = cesarean delivery, OR = odds ratio, CI = confidence interval, NS = not significant.

Adverse neonatal/maternal outcomes in total study population including both cases with elective and emergency CD

The relationship between the planned GAD and risk of adverse neonatal/maternal outcomes were determined in total study population including both cases with elective cesarean and emergency CD. As shown in Table 4, the risk of adverse neonatal outcomes decreased significantly with advancing planned GAD. The rate of adverse maternal outcomes did not differ according to the planned GAD (P = not significant).

Table 4

Clinical characteristics and adverse neonatal/maternal outcomes according to the GAD in total study population including both elective and emergency CD

Characteristics			37–37+6 wk (n = 103)	38–38+6 wk (n = 681)	39–39+6 wk (n = 236)	≥ 40 wk (n = 15)	Pa	Pb
Maternal characteristics
	Maternal age, yr		33 ± 4	33 ± 4	34 ± 4	32 ± 3	NS	NS
	Marriedc		97/98 (99)	641/644 (99.5)	228/228 (100)	14/14 (100)	NS	NS
	Nulliparityc		27 (26)	188 (28)	82 (35)	8 (53)	< 0.050	< 0.050
Indications for CDc							< 0.001	< 0.001
	Previous CD		70 (68)	459 (67)	130 (55)	5 (33)
	Malpresentation		14 (14)	108 (16)	69 (29)	7 (47)
	Previous uterine surgery		8 (8)	67 (10)	14 (6)	0 (0)
	Others		11 (11)	47 (7)	23 (10)	3 (20)
Emergency CDd			6 (5.8)	56 (8.2)	32 (13.6)	4 (26.7)	< 0.005	< 0.010
GAD, wk			37.6 ± 0.3	38.4 ± 0.3	39.1 ± 0.4	40.2 ± 0.8	< 0.001
Neonatal characteristics
	Malec		52 (51)	334 (49)	119 (50)	6 (40)	NS	NS
	Birthweight, g		3,171 ± 363	3,201 ± 352	3,323 ± 438	3,510 ± 426	< 0.001	< 0.001
	Small for gestational agec		1 (1)	22 (3)	15 (6)	0 (0)	< 0.050	< 0.050
Adverse neonatal outcomesd
	Any adverse outcome or death		10 (9.7)	34 (5.0)	7 (3.0)	1 (6.7)	< 0.050	< 0.050
		Mortality	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		RDS or TTN	1 (1.0)	6 (1.0)	0 (0)	0 (0)	NS	NS
		Need for respiratory assistant such as CPAP or ventilator	2 (1.9)	3 (0.4)	0 (0)	0 (0)	< 0.050	< 0.050
		Proven sepsis	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Hypoglycemia (< 35 mg/dL)	0 (0)	3 (0.4)	0 (0)	0 (0)	NS	NS
		Admission to the NICU	5 (4.9)	6 (0.9)	4 (1.7)	1 (6.7)	NS	NS
		5-min Apgar score ≤ 3	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Hospitalization > 10 day	8 (7.8)	18 (2.6)	5 (2.1)	0 (0)	< 0.050	< 0.050
Adverse maternal outcomesd
	Any adverse outcome or death		4 (4)	42 (6)	14 (6)	1 (7)	NS	NS
		Death	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Uterine artery embolization	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Hysterectomy	0 (0)	1 (0.1)	0 (0)	0 (0)	NS	NS
		Cystostomy	0 (0)	4 (0.6)	2 (0.8)	0 (0)	NS	NS
		Uterine artery ligation	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Transfusion	4 (4)	27 (4)	4 (2)	1 (8)	NS	NS
		Atony	0 (0)	11 (2)	6 (3)	0 (0)	NS	NS
		Uterine rupture	0 (0)	1 (0.1)	0 (0.4)	0 (0)	NS	NS
		Wound dehiscence	0 (0)	4 (1)	0 (0)	0 (0)	NS	NS
		Admission in the intensive care unit	0 (0)	2 (0.3)	0 (0)	0 (0)	NS	NS
		Endometritis	0 (0)	1 (0.1)	0 (0)	0 (0)	NS	NS
		Thromboembolic complication	0 (0)	0 (0)	0 (0)	0 (0)	-	-
		Postoperative ileus	0 (0)	3 (0.4)	2 (0.8)	0 (0)	NS	NS

Data are shown as mean ± standard deviation or number (%).

GAD = gestational age at delivery, CD = cesarean delivery, RDS = respiratory distress syndrome, TTN = transient tachypnea of newborn, CPAP = continuous positive airway pressure, NICU = neonatal intensive care unit, NS = not significant.

aP tested for total; bP tested from 37 to 39 weeks only; cAnalyzed by χ2 test; dAnalyzed by χ2 test for trend.

DISCUSSION

The main findings of the current study were: 1) the risk of emergent operation increased significantly with increasing planned GAD for elective CD; 2) the risk of adverse maternal outcomes was greater in cases of emergent CD compared to elective CD, whereas the risk of adverse neonatal outcomes did not differ; 3) in the total study population including both cases with elective and emergency operation, the risk of adverse maternal outcomes did not increase according to the planned GAD, and the risk of adverse neonatal outcomes decreased significantly according to the planned GAD.

To our knowledge, this is the first study which assessed the risk of emergency CDs and adverse neonatal/maternal outcomes according to the planned GAD for elective CDs. Indeed, most studies of adverse neonatal or maternal outcomes and the timing of CDs are based on elective CDs after excluding cases with emergent CD.

Previous studies have indicated that the risk of adverse neonatal outcomes in elective term CDs decreases progressively with increasing gestational age at birth.278911 According to this evidence, performing elective CD prior to 39 weeks of gestation is discouraged. However, delaying delivery until 39 weeks may increase the risk of emergent CDs, and the outcome of this particular group has not been adequately addressed in the literature.12 In the current study, we examined the frequency and risk among this group undergoing emergent delivery with regards to both neonatal and maternal outcomes. As a result, the risk of emergency operation was increased in cases according to advance planned GAD, and maternal morbidity was higher in cases with emergency CD. However, the total risk of adverse maternal outcomes did not increase according to the advance planned GAD, when including both cases with elective and emergent CD, and the total risk of adverse neonatal outcomes decreased significantly according to the advanced planned GAD.

In the literature, the impacts of emergent CD on adverse neonatal outcomes in patients who are candidates for elective CDs are controversial. Neonatal respiratory morbidity has been shown to decrease in cases of emergent CD after the onset of labor,31314 although other studies have failed to demonstrate this relationship.1115 In addition, the onset of labor in cases among women who have undergone previous cesarean is associated with lower cord pH, neonatal sepsis, iatrogenic fetal injury, uterine rupture, and intrapartum fetal death.131416 In the current study, the risk of adverse neonatal outcomes was not increased among emergent CDs.

Until now, few studies have addressed maternal morbidity according to the GAD.17 In elective CD, maternal morbidity does not appear to be affected by the GAD.10 In terms of emergency CD, the risk of onset of labor before 39 weeks was 10%–25%,39 and concerns about an increased risk of maternal mortality and morbidity, such as excessive blood loss, uterine rupture and infections in intrapartum CD, compared to elective CD have also been suggested in emergency operation.9121819202122 In the current study, the risk of emergent CD increased significantly with increasing planned GAD, and maternal morbidity was greater in cases of emergent CD. In multiple logistic regression analysis, emergent CD remained a risk factor for adverse maternal morbidity even after adjustment for GAD. However, only the risk of wound dehiscence was increased in emergency CD than in elective CD in the current study, whereas the risk of severe maternal, such as excessive blood loss, uterine rupture and endometritis was not significantly increased. Moreover, when including both cases with elective and emergency operation, the maternal morbidity was not increased according to the planned GAD.

The results of the current study may be used for the counseling women regarding the planning of the gestational age at elective CD. Planning of elective CD at 39 weeks or later is encouraged to decrease the risk of neonatal respiratory morbidity; however it carries the higher risk of emergent CD, which can result in maternal, though not neonatal, morbidity. In addition, emergent CD carries the risk of lower medical service qualities in terms of operating facilities and health professionals, especially in resource-constrained countries.23 However, as a total (when including both cases with elective and emergency operation), the maternal morbidity was not increased according to the planned GAD. And the neonatal morbidity was decreased according to planned gestational age, as a total.

The limitation of the current study is the nature of the current study which is retrospective study; further prospective randomized trials may be needed to compare the risk and benefit according to the timing of elective CD.

Further studies may be needed to evaluate the risk of other adverse outcomes and the planned gestational age for CD. In the current study, we excluded cases of fetal death in utero, cases with maternal disease such as hypertensive disease in pregnancy or clinical chorioamnionitis prior to delivery, and cases with a non-reassuring fetal status or placental abruption; all of these may develop while awaiting elective delivery at 39 weeks or later.2425 Therefore, the risk versus benefit of postponing elective CD until 39 weeks of gestation also needs to be evaluated with regards to these complications.

No prospective randomized trials have been conducted to compare the risk and benefit between the timing of elective CD before and after 39 weeks of gestation.12 From the results of the current study and previous retrospective studies, we may postulate that neonatal respiratory morbidities may be lower but maternal morbidities may be similar in the strategies of timing of elective CD after 39 weeks of gestation. Additionally, other neonatal morbidities such as perinatal mortality should be evaluated. The determination of optimal delivery timing for elective CD is very important issue, considering that the CD rate is about 20%–40% in various countries and 35% in Korea.26

In conclusion, the risk of emergent CD increased with increasing planned gestational age for elective CD, and the risk of adverse maternal outcomes was higher with emergent CD. However, the risk of adverse maternal outcomes did not increase according to the planned gestational age in the total study population including both cases with elective and emergency CD.